rs200444154
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_005883.3(APC2):c.5108C>A(p.Ala1703Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000888 in 1,588,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005883.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| APC2 | ENST00000590469.6 | c.5108C>A | p.Ala1703Glu | missense_variant | Exon 15 of 15 | 1 | NM_005883.3 | ENSP00000467073.2 | ||
| APC2 | ENST00000233607.6 | c.5108C>A | p.Ala1703Glu | missense_variant | Exon 15 of 15 | 1 | ENSP00000233607.2 | |||
| APC2 | ENST00000535453.5 | c.5108C>A | p.Ala1703Glu | missense_variant | Exon 14 of 14 | 1 | ENSP00000442954.1 | |||
| C19orf25 | ENST00000588427.5 | c.131-6585G>T | intron_variant | Intron 2 of 2 | 1 | ENSP00000468000.1 |
Frequencies
GnomAD3 genomes AF: 0.000959 AC: 146AN: 152248Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000519 AC: 107AN: 206256 AF XY: 0.000512 show subpopulations
GnomAD4 exome AF: 0.000881 AC: 1265AN: 1436626Hom.: 0 Cov.: 34 AF XY: 0.000865 AC XY: 616AN XY: 712468 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000958 AC: 146AN: 152366Hom.: 0 Cov.: 33 AF XY: 0.000913 AC XY: 68AN XY: 74504 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
This sequence change replaces alanine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 1703 of the APC2 protein (p.Ala1703Glu). This variant is present in population databases (rs200444154, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with APC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 493243). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Variant summary: APC2 c.5108C>A (p.Ala1703Glu) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change. The variant allele was found at a frequency of 0.00052 in 206256 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in APC2 causing APC2-Related Disorders, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.5108C>A in individuals affected with APC2-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 493243). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Inborn genetic diseases Uncertain:1
The c.5108C>A (p.A1703E) alteration is located in exon 15 (coding exon 14) of the APC2 gene. This alteration results from a C to A substitution at nucleotide position 5108, causing the alanine (A) at amino acid position 1703 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Intellectual developmental disorder, autosomal recessive 74;C5231458:Cortical dysplasia, complex, with other brain malformations 10 Uncertain:1
- -
Intellectual developmental disorder, autosomal recessive 74 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at